Originally published by CIDRAP News Oct 13
The World Health Organization (WHO) warned today that efforts to reduce the global burden of tuberculosis (TB) need to move faster to meet international targets, and that detection and treatment gaps remain a significant roadblock in the fight against multidrug-resistant TB (MDR-TB).
A new study in PLoS One suggests that companion animals may be a potential source of community-acquired Clostridium difficile infection (CDI) in humans.
Although MCR-1 has often garnered drug-resistance headlines of late, an earlier gene that also confers antimicrobial resistance, NDM-1 (New Delhi metallo-beta-lactamase) has not gone away, as evidenced by a study yesterday in Emerging Infectious Diseases. Researchers reported the gene in 27 Vibrio fluvialis isolates in Kolkata, India.
Experts say screening at-risk adults for latent TB likely yields moderate benefits.
New data from the Centers for Disease Control and Prevention (CDC) shows that there were 3,250 likely cases of severe MERS-CoV in the Middle East between Sept 2012 and Jan 2016. This number is 2.3-fold higher than current laboratory confirmed cases, suggesting that the disease is more widespread than previously thought.
SAB Biotherapeutics, Inc., of Sioux Falls, S.D., announced today that its experimental human antibody treatment for MERS-CoV—called SAB-301—has entered human trials, the first potential treatment for the disease to do so.
A study yesterday in the Journal of Infectious Diseases suggests that although the Ebola outbreak originating in West Africa in 2013 was the deadliest to date, that strain of Ebola virus (EBOV) did not possess more aerosol stability than a strain of 1976 EBOV.
In its weekly yellow fever situation report, the World Health Organization (WHO) today noted 73 more cases of the disease in Angola, bringing that country's suspected cases to 3,625.
Utah health officials today announced the first known Zika death in the continental United States, in a Salt Lake County resident who died in late June.
